BCM
ASTH icon

Bayesian Capital Management’s Astrana Health ASTH Stock Holding History

Bayesian Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,536
Closed -$317K – 1132
2022
Q1 		$317K Buy
+6,536
New +$337K 0.05% 505

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bayesian Capital Management's ASTH Position: Q2 2022 in Review

Bayesian Capital Management sold out of Astrana Health (ASTH) in Q2 2022, closing a stake of 6,536 shares — an estimated $317K sold.

Bayesian Capital Management first reported a position in ASTH in Q1 2022 and held it in 1 quarter. The position peaked at $317K in Q1 2022. 134 funds tracked by Wall St. Rank hold ASTH as of Q2 2022.

  • Bayesian Capital Management reported no remaining Astrana Health position as of Q2 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 6,536 Astrana Health shares in Q2 2022, an estimated $317K.
  • Bayesian Capital Management first reported a position in Astrana Health in Q1 2022 and held it in 1 quarter.
  • Bayesian Capital Management's Astrana Health position peaked at $317K in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Astrana Health as of Q2 2022.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.